Research progress on hepatitis E virus and blood safety
Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 4
Abstract
Hepatitis E virus (HEV) is one of the main reasons of acute viral hepatitis. Although the majority of hepatitis E virus infection in humans is transmitted by fecal-oral route around the world, transfusion-transmitted HEV (TT-HEV) has attracted more and more attention as an emerging global health problem. Worldwide, 0.001 3%-0.281 0% of blood donors are HEV virus asymptomatic infection, and 0.27%-60.50% of blood donors have anti-HEV immunoglobulin antibody IgG. Blood recipient could get infected with HEV even if viral load in the blood is extremely low, which poses a great threat to blood safety. Therefore, HEV screening in blood donors has become an important concern in many countries. This article reviews the evidence and typical cases of TT-HEV, as well as the detection protocols and results of HEV screening in different countries, in order to provide evidence for whether HEV screening should be included in routine screening items for voluntary blood donors in China.
Authors and Affiliations
Miao LIU
Keywords
Related Articles
- EP ID EP738536
- DOI 10.13303/j.cjbt.issn.1004-549x.2023.04.017
- Views 37
- Downloads 0
Effect of multiple apheresis platelet donation on platelet indexes and aggregation rate in platelet donors
Objective To investigate the effect of multiple apheresis platelet donation on platelet indexes and aggregation function in platelet donors, and to analyze the relationship between platelet indexes and their relationship...
Efficacy and safety of platelet-rich plasma for acute achilles tendon injury: a meta-analysis
Objective To evaluate the clinical efficacy and safety of platelet-rich plasma(PRP) in acute achilles tendon injury by meta-analysis. Methods Literature on clinical randomized controlled trial of PRP in the treatment of...
Progress in the construction of immortalized cells
Objective In the process of proliferation and division, normal human cells reach the mortality stage M1 and mortality stage M2, which makes the cells stop division and apoptosis. This irreversible physiological process i...
Study on relationship between platelet transfusion efficacy and KIR-HLA receptor-ligand compatibility
Objective To study the correlation between platelet transfusion efficacy and KIR receptor-HLA ligand. Methods Thirty-three leukemia patients with positive HLA antibody were tested for cross-matching with donor platelets....
Unexpected antibody distribution among tumor patients: analysis of 111 483 cases
Objective To analyze the distribution of unexpected antibodies in tumor patients retrospectively and explore the clinical significance. Methods Unexpected antibody screening was performed on inpatients with blood prepara...